MyFinsight
Home
About
Contact
Back
Income Statement
Aspire Biopharma Holdings, Inc. (ASBP)
source: myfinsight.com
Download
Download image
Net loss
-$1,981,293
Total other (expense)
income, net
-$1,181,403
Total operating
expenses
$799,890
Change in fair value of
derivative liability
-$289,401
Loss on
extinguishment of debt
-$364,109
Interest expense
$527,893
General and
administrative expenses
$395,692
Research and development
$352,887
Sales and marketing
$51,311
Back